Torrent Pharmaceuticals Ltd.

NSE: TORNTPHARM | BSE: 500420 | ISIN: INE685A01028 | Industry: Pharmaceuticals
| Expensive Performer
3612.9000 33.80 (0.94%)
NSE Sep 08, 2025 15:31 PM
Volume: 166.1K
 

3612.90
0.94%
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Revenues declined 20.6% YoY to | 1545 crore (I-direct estimate: | 1587.0 crore) mainly due to 51.1% YoY de-growth in the US to | 434 crore (I-direct estimate: | 497.3 crore). The decline in US sales was due to the high base of gAbilify exclusivity in Q1FY16 EBITDA margins declined 1840 bps to 28.3% (I-direct estimate: 30%)....
Sharekhan decreased Buy price target of Torrent Pharmaceuticals Ltd. to 4024.0 on 29 Aug, 2025.
More from Torrent Pharmaceuticals Ltd.
Recommended